Recent Advances in Immunotherapy for Allergic Diseases

ISSN: 2212-2710 (Online)
ISSN: 1872-213X (Print)

Volume 9, 2 Issues, 2015

Download PDF Flyer

Recent Patents on Inflammation & Allergy Drug Discovery

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Recent Advances in Immunotherapy for Allergic Diseases

Author(s): David El-Qutob, Gemma Mencia and Enrique Fernandez-Caldas

Affiliation: Unit of Allergy, Hospital La Plana, Carretera Vila-Real-Burriana Km. 0.5 Vila-Real (Castellon) 12540, Spain.


Allergic diseases are a major health problem worldwide. The therapeutic approaches to treat allergic rhinitis (AR) and allergic asthma (AA) fall in three major categories. The first step is allergen avoidance, or reduction of exposure to the offending allergen(s). The second and most widely used therapeutic practice is the prescription of relevant medication to reduce symptoms. The third therapeutic element is specific allergy vaccination, also known as allergen specific immunotherapy. Allergen-specific immunotherapy (SIT) is the only etiologic treatment of allergic disorders that can alter the natural course of the disease. In this review, recent advances in immunotherapy and relevant patents are presented. General vaccine modifications could be applied for any type of allergen. New specific modifications in allergic vaccines have been developed for a variety of allergies such as house dust mites, horse, cat, parvalbumin and from birch, ragweed and parietaria pollen.

Keywords: Allergoid, allergy, asthma, house dust mite, immunotherapy, parvalbumin, rhinitis.

Download Free Order Reprints Order Eprints Rights and Permissions


Article Details

Volume: 8
Issue Number: 1
First Page: 24
Last Page: 35
Page Count: 12
DOI: 10.2174/1872213X07666131113111159

Related Journals

Webmaster Contact: Copyright © 2015 Bentham Science